Athena Pharmaceutiques Oral Dispersible Tablets

Athena Pharmaceutiques Oral Dispersible Tablets

X

Digital content for Kriya Therapeutics

Kriya Therapeutics

KRIYA THERAPEUTICS

About, Contact Details

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

PRESENTATION(s)

No Presentations

VIDEO(s)

No Video

DIGITAL CONTENT

13 News

13 News

DEVELOPMENTS

6 Drug(s) in Development

6 Drug(s) in Development

Full View Screen

Full Screen View

Kriya buys Redpin to chart gene therapy course in neurology

Kriya buys Redpin to chart gene therapy course in neurology

Max Bayer FIERCEBIOTECH

17 Nov 2022

Kriya Appoints Curt Herberts as President and Chief Operating Officer

Kriya Appoints Curt Herberts as President and Chief Operating Officer

BUSINESSWIRE

25 Aug 2022

Kriya banks $270M series C to be one-stop shop in gene therapy

Kriya banks $270M series C to be one-stop shop in gene therapy

Max Bayer FIERCEBIOTECH

16 May 2022

Twist's antibodies to wind up with Kriya's AAV gene therapies

Twist's antibodies to wind up with Kriya's AAV gene therapies

K. LaHucik FIERCEBIOTECH

10 Mar 2022

Kriya Appoints Ma’an Muhsin, as President & CMOr of Oncology Division

Kriya Appoints Ma’an Muhsin, as President & CMOr of Oncology Division

BUSINESSWIRE

03 Feb 2022

Kriya Licenses Next Generation Complement-Targeted Gene Therapies

Kriya Licenses Next Generation Complement-Targeted Gene Therapies

BUSINESSWIRE

26 Jan 2022

Kriya Expands Gene Therapy Pipeline, Establishes Rare Disease Therapeutic Area

Kriya Expands Gene Therapy Pipeline, Establishes Rare Disease Therapeutic Area

BUSINESSWIRE

07 Jan 2022

Kriya Appoints Theresa Heah as CMO and President of Kriya Ophthalmology

Kriya Appoints Theresa Heah as CMO and President of Kriya Ophthalmology

BUSINESSWIRE

14 Oct 2021

Kriya Completes Renovation of Facility for Scalable Gene Therapy Manufacturing

Kriya Completes Renovation of Facility for Scalable Gene Therapy Manufacturing

BUSINESSWIRE

29 Jul 2021

Imago BioSciences, Inc. Announces Pricing of Upsized Initial Public Offering

Imago BioSciences, Inc. Announces Pricing of Upsized Initial Public Offering

PHARMACEUTICAL TECHNOLOGHY

15 Jul 2021

laboratorium-ofichem-b-v-m-2023-03-20

Access Virtual Booth

Contact Supplier

Send me more info on How To Grow My Business Digitally?

Market Place

Home

Menu

Post Enquiry

Market Place

Search